Best of the Week
Most Popular
1. Stock Markets and the History Chart of the End of the World (With Presidential Cycles) - 28th Aug 20
2.Google, Apple, Amazon, Facebook... AI Tech Stocks Buying Levels and Valuations Q3 2020 - 31st Aug 20
3.The Inflation Mega-trend is Going Hyper! - 11th Sep 20
4.Is this the End of Capitalism? - 13th Sep 20
5.What's Driving Gold, Silver and What's Next? - 3rd Sep 20
6.QE4EVER! - 9th Sep 20
7.Gold Price Trend Forecast Analysis - Part1 - 7th Sep 20
8.The Fed May “Cause” The Next Stock Market Crash - 3rd Sep 20
9.Bitcoin Price Crash - You Will be Suprised What Happens Next - 7th Sep 20
10.NVIDIA Stock Price Soars on RTX 3000 Cornering the GPU Market for next 2 years! - 3rd Sep 20
Last 7 days
Gold/SPX Ratio and the Gold Stock Case - 18th Jan 21
More Stock Market Speculative Signs, Energy Rebound, Commodities Breakout - 18th Jan 21
Higher Yields Hit Gold Price, But for How Long? - 18th Jan 21
Some Basic Facts About Forex Trading - 18th Jan 21
Custom Build PC 2021 - Ryzen 5950x, RTX 3080, 64gb DDR4 Specs - Scan Computers 3SX Order Day 11 - 17th Jan 21
UK Car MOT Covid-19 Lockdown Extension 2021 - 17th Jan 21
Why Nvidia Is My “Slam Dunk” Stock Investment for the Decade - 16th Jan 21
Three Financial Markets Price Drivers in a Globalized World - 16th Jan 21
Sheffield Turns Coronavirus Tide, Covid-19 Infections Half Rest of England, implies Fast Pandemic Recovery - 16th Jan 21
Covid and Democrat Blue Wave Beats Gold - 15th Jan 21
On Regime Change, Reputations, the Markets, and Gold and Silver - 15th Jan 21
US Coronavirus Pandemic Final Catastrophe 2021 - 15th Jan 21
The World’s Next Great Onshore Oil Discovery Could Be Here - 15th Jan 21
UK Coronavirus Final Pandemic Catastrophe 2021 - 14th Jan 21
Here's Why Blind Contrarianism Investing Failed in 2020 - 14th Jan 21
US Yield Curve Relentlessly Steepens, Whilst Gold Price Builds a Handle - 14th Jan 21
NEW UK MOT Extensions or has my Car Plate Been Cloned? - 14th Jan 21
How to Save Money While Decorating Your First House - 14th Jan 21
Car Number Plate Cloned Detective Work - PY16 JXV - 14th Jan 21
Big Oil Missed This, Now It Could Be Worth Billions - 14th Jan 21
Are you a Forex trader who needs a bank account? We have the solution! - 14th Jan 21
Finetero Review – Accurate and Efficient Stock Trading Services? - 14th Jan 21
Gold Price Big Picture Trend Forecast 2021 - 13th Jan 21
Are Covid Lockdowns Bullish or Bearish for Stocks? FTSE 100 in Focus - 13th Jan 21
CONgress "Insurrection" Is Just the Latest False Flag Event from the Globalists - 13th Jan 21
Reflation Trade Heating Up - 13th Jan 21
The Most Important Oil Find Of The Next Decade Could Be Here - 13th Jan 21
Work From Home £10,000 Office Tour – Workspace + Desk Setup 2021 Top Tips - 12th Jan 21
Collect a Bitcoin Dividend Without Owning the King of Cryptos - 12th Jan 21
The BAN Hotlist trade setups show incredible success at the start of 2021, learn how you can too! - 12th Jan 21
Stocks, Bitcoin, Gold – How Much Are They Worth? - 12th Jan 21
SPX Short-term Top Imminent - 12th Jan 21
Is This The Most Exciting Oil Play Of 2021? - 12th Jan 21
Why 2021 Will Be the Year Self-Driving Cars Go Mainstream - 11th Jan 21
Gold Began 2021 With a Bang, Only to Plunge - 11th Jan 21
How to Test Your GPU Temperatures - Running Too Hot - GTX 1650 - Overclockers UK - 11th Jan 21
Life Lesson - The Early Bird Catches the Worm - 11th Jan 21
Precious Metals rally early in 2021 - 11th Jan 21
The Most Exciting Oil Stock For 2021 - 11th Jan 21
Financial Market Forecasts 2021: Navigation in Uncharted Waters - 10th Jan 21
An Urgent Message to All Conservatives, Right-Wingers and Patriots - 10th Jan 21
Despite Signs to the Contrary, Gold Price at or Near Top - 10th Jan 21 -
Ultimate Guide On The 6 Basic Types Of Index Funds - 10th Jan 21
Getting Vaccinated at TESCO - Covid-19 Vaccinations at UK Supermarket Pharmacies and Chemists - 10th Jan 21
Cheers for the 2021 Stock Market and These "Great Expectations" - 9th Jan 21
How to Plan Your Child With Better Education - 9th Jan 21
How To Find The Best Casino - 9th Jan 21
Gold Is Still a Bargain Buy - 8th Jan 20
Gold Price Set to Soar as Hyperinflation Looms - 8th Jan 21
Have Big Dreams? Here's How to Pay for Them - 8th Jan 21
Will the Fed Support Gold Prices in 2021? - 8th Jan 21
Stocks trading strategies for beginners - 8th Jan 21
Who is Buying and Selling Stocks in 2021 - 8th Jan 21
Clap for NHS Heroes 2021 as Incompetent Government Loses Control of Virus Again! - 8th Jan 21

Market Oracle FREE Newsletter

FIRST ACCESS to Nadeem Walayat’s Analysis and Trend Forecasts

Stock Market Gains, but the “Super Crash” Is Accelerating

Stock-Markets / Financial Crash Oct 11, 2015 - 07:59 PM GMT

By: MM

Stock-Markets Michael E. Lewitt writes: The lunatics are running the asylum.

After an incessant flow of bad economic news from both the U.S. and abroad, investors decided that "bad news is good news" and they should bid up stock prices.

Saying "bad is good" is like saying "down is up" or "Hillary is telling the truth."  It is so obviously contrary to the facts that you can't take it seriously.

And yet investors, in their infinite wisdom, decided that the economic news is so bad that the Federal Reserve (which itself doesn't know up from down) is not going to raise interest rates.

It's not clear how long this insanity will last, but I wouldn't be chasing stock prices here.

And here's why…

There's Nothing Solid Underneath Last Week's Gains

It won't make much of a difference if the Fed does raise rates by year-end. At most they will move by 25 basis points, which is like a flea on an elephant's back.

The primary effect of such a move would be to further strengthen the dollar, which in turn would keep the pressure on commodity prices.

Markets are likely correct that the Fed isn't going to raise rates by year end. My bet is that they won't raise them as long as President Obama is in office.

But that doesn't mean those same markets are reaching the right conclusion in bidding up stock prices. A weak global economy that is on the verge of recession is bad for stocks.

There's no doubt much of last week's strong gains in stocks was due to short covering.

The Dow Jones Industrial Average added a strong 3.7% to 17084.49 while the S&P 500 rose by 3.3% to 2014.89 and the Nasdaq Composite Index added 2.2% to 4830.47.

These were the strongest gains for the Dow and S&P 500 for the year. The Chicago Board Options Exchange Volatility Index (VIX) dropped to 17.08, its lowest level since August 18.

On the surface, markets were looking good last week – but do not be fooled.

Most of the Indexes Are Dead

Only the capitalization-weighted indexes are showing a pulse after a brutal pummeling over the last two months. But much of the rest of the market is solidly in bear market territory with losses of 20% or more in anything remotely related to energy, commodities or basic industry.

The junk bond market has also sold off sharply, following commodities and stocks into a tailspin.

There are a lot of fund managers and pundits who have been 100% wrong about the market this year and are desperately praying for a huge fourth quarter rally to bail out their reputations (and pad their bonuses).

Unfortunately, there is very little good news on which to base such a rally.

You see, third quarter GDP clocked in at under 1% on the Atlanta Fed's GDPNow model. First quarter GDP will likely be weak again next year.

So the big question is whether fourth quarter GDP is going to be anything to write home about – because if it isn't, the US economy could see three consecutive quarters of growth averaging very close to 1%. That may not meet the official definition of a recession, but it's damned close.

Third quarter earnings are just starting to be reported and are expected to be lousy. Bad news better be good news because that's likely to be all there is in the weeks and months ahead.

Watch These Stocks Closely for Short Profits

Investors should keep their eyes on a few key stocks in the weeks ahead.

Glencore PLC (LSE: GLEN), one of the world's biggest commodities traders – which I've written about at Sure Money Investor – has doubled since its recent lows as short-sellers have covered their positions and a few true believers have bought the company's thin assurances that it isn't a house of cards.

Glencore's debt and credit default swaps are still trading as though the company is far from out of the woods, which is a much more accurate picture of its true financial status. Glencore remains at high risk of losing its investment-grade rating, which would trigger a host of problems for the company as well as for financial markets.

Stay tuned here and at Sure Money Investor for more on this company, its stock and the fallout its failure will create.

Meanwhile, there's another systemically important firm that's flirting with disaster.

An Unfathomably Huge (and Dangerous) Loose Cannon

Deutsche Bank AG (USA) (NYSE:DB) announced a multi-billion dollar write-off last week. I have been watching DB for a while as its stock price has been cut in half over the past couple of years.

Deutsche Bank  has $75 trillion – with a "T" – worth of derivatives on its books and has been in trouble with the New York Fed over lax reporting as well as a serial law breaker that has paid billions of dollars of fines to the government in legal settlements.

It has poor management, lax financial controls and, as its write-off suggest, a lot of bad assets on its books. Of course, Deutsche Bank is a "too big to fail" global institution, which really means it is "too big to save." As one of the biggest banks in the world, trouble for Deutsche Bank spells trouble for the global financial system.

They're not the only ones in trouble.

Greedy Pharma Executives Hoisted by Their Own Petards

Finally, Valeant Pharmaceuticals Intl. Inc. (NYSE:VRX) has seen its stock get squashed as politicians start paying attention to egregious drug price increases in the pharmaceutical industry. But Valeant's stock collapse has coincided with a broader selloff in the biotech space, which has been in a bubble for the last year or so.

The iSharesNasdaq Biotechnology Index ETF (NYSEArca:IBB) has dropped more than 23% from its 52-week high of $400.79 to $308.45 per share.

But Valeant is even more interesting because its business model involves buying other drug companies using huge amounts of debt, firing most of their employees and raising the prices of their drugs by huge percentages.

Even better, one of Valeant's largest investors is the activist Bill Ackman, who acquired his stock in the company in a manner that pushed the boundaries of insider trading laws.

Valeant's business model relies on its ability to keep doing acquisitions with low cost borrowed money, something that is going to be harder to do if it can no longer raise drug prices at will.

This company is worth watching not only for its own stock performance for what it means for the biotech sector, drug prices and the healthcare industry, activist investing and the fate of highly leveraged companies as we come to the (bitter) end of the "Debt Supercycle."

Michael Lewitt is following the unfolding "Super Crash" at Sure Money Investor, and he's showing his readers how to make a killing off the sliding stocks and bubble sectors you've just read about and more. Click here to get Sure Money Investor yourself at no charge, and you'll get his Super Crash report, too. It shows you exactly what to do to protect yourself and take profits from this crash.


Money Morning/The Money Map Report

©2015 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email:

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

© 2005-2019 - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.

Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules